메뉴 건너뛰기




Volumn 49, Issue 3, 2004, Pages 211-216

Erratum: Experiences in method development for the analysis of in vitro study solutions for content (Journal of Pharmacological and Toxicological Methods (2004) 49 (211-216) DOI 10.1016/j.vascn.2004.03.003);Experiences in method development for the analysis of in vitro study solutions for content

Author keywords

Bath solutions; HERG; LC MS analysis; Methods; Purkinje; Safety margin; Solubility

Indexed keywords

POTASSIUM CHANNEL HERG;

EID: 2542460073     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2004.08.003     Document Type: Erratum
Times cited : (11)

References (7)
  • 1
    • 20244385131 scopus 로고    scopus 로고
    • The Merck index
    • Whitehouse Station, NJ: Merck
    • Budavari S. The Merck index. 12th edition:1996;Merck, Whitehouse Station, NJ
    • (1996) 12th Edition
    • Budavari, S.1
  • 2
    • 0003484310 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001.
    • FDA. (2001). Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001.
    • (2001) Guidance for Industry, Bioanalytical Method Validation
  • 3
    • 0003228192 scopus 로고
    • ICHQ2A: Text on validation of analytical procedures
    • Federal Register ICHQ2A: Text on validation of analytical procedures. Federal Register. 60:1995;11260
    • (1995) Federal Register , vol.60 , pp. 11260
    • Register, F.1
  • 4
    • 0035854839 scopus 로고    scopus 로고
    • ICHS7A: Safety pharmacology studies for human pharmaceuticals
    • Federal Register ICHS7A: Safety pharmacology studies for human pharmaceuticals. Federal Register. 66:2001;36791-36792
    • (2001) Federal Register , vol.66 , pp. 36791-36792
    • Register, F.1
  • 5
    • 2542499263 scopus 로고    scopus 로고
    • ICHS7B: Safety pharmacology studies for assessing the potential for delayed ventricular repolarisation (QT interval prolongation) by human pharmaceuticals
    • in preparation
    • Federal Register ICHS7B: Safety pharmacology studies for assessing the potential for delayed ventricular repolarisation (QT interval prolongation) by human pharmaceuticals. Federal Register. 67:2002;40950-40951. in preparation
    • (2002) Federal Register , vol.67 , pp. 40950-40951
    • Register, F.1
  • 6
    • 0003576886 scopus 로고
    • Clarke's isolation and identification of drugs
    • London: The Pharmaceutical Press
    • Moffat A.C. Clarke's isolation and identification of drugs. 2nd edition:1986;The Pharmaceutical Press, London
    • (1986) 2nd Edition
    • Moffat, A.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.